Cargando…

miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin Resistance

Approximately 70% of women with polycystic ovary syndrome (PCOS) have intrinsic insulin resistance (IR) above and beyond that associated with body mass, including dysfunctional glucose metabolism in adipose tissue (AT). In AT, analysis of the IRS/PI3-K/AKT pathway signaling components identified onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yen-Hao, Heneidi, Saleh, Lee, Jung-Min, Layman, Lawrence C., Stepp, David W., Gamboa, Gloria Mabel, Chen, Bo-Shiun, Chazenbalk, Gregorio, Azziz, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712080/ https://www.ncbi.nlm.nih.gov/pubmed/23493574 http://dx.doi.org/10.2337/db12-0963

Ejemplares similares

SAT386 Constitutive Overexpression Of Microrna-93 As A Cause Of Metabolic Dysfunction And Hyperandrogenism In Polycystic Ovary Syndrome (PCOS): Evidence From A Transgenic (Mir-93+) Murine Model
por: Chen, Yen-Hao, et al.
Publicado: (2023)

An Evolutionary Model for the Ancient Origins of Polycystic Ovary Syndrome
por: Dumesic, Daniel A., et al.
Publicado: (2023)

MON-223 Adipose Insulin Resistance in Normal-Weight Women with Polycystic Ovary Syndrome
por: Hoyos, Luis, et al.
Publicado: (2019)

Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation
por: Dumesic, Daniel A., et al.
Publicado: (2022)

Novel Pathway of Adipogenesis through Cross-Talk between Adipose Tissue Macrophages, Adipose Stem Cells and Adipocytes: Evidence of Cell Plasticity
por: Chazenbalk, Gregorio, et al.
Publicado: (2011)

Awakened by Cellular Stress: Isolation and Characterization of a Novel Population of Pluripotent Stem Cells Derived from Human Adipose Tissue
por: Heneidi, Saleh, et al.
Publicado: (2013)

Correction: Awakened by Cellular Stress: Isolation and Characterization of a Novel Population of Pluripotent Stem Cells Derived from Human Adipose Tissue
por: Heneidi, Saleh, et al.
Publicado: (2013)

Interplay of Cortisol, Testosterone, and Abdominal Fat Mass in Normal-weight Women With Polycystic Ovary Syndrome
por: Dumesic, Daniel A, et al.
Publicado: (2023)

MicroRNA-223 Expression Is Upregulated in Insulin Resistant Human Adipose Tissue
por: Chuang, Tung-Yueh, et al.
Publicado: (2015)

Serum Testosterone to Androstenedione Ratio Predicts Metabolic Health in Normal-Weight Polycystic Ovary Syndrome Women
por: Dumesic, Daniel A, et al.
Publicado: (2021)

Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
por: Mathur, Ruchi, et al.
Publicado: (2008)

The polycystic ovary syndrome: the first 150 years of study
por: Adashi, Eli Y., et al.
Publicado: (2022)

Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
por: Sathyapalan, T., et al.
Publicado: (2015)

OR20-03 Transcriptional Changes in Lipid Metabolism of Adipocytes Derived from Subcutaneous Abdominal Adipose Stem Cells of Normal-Weight Polycystic Ovary Syndrome Women
por: Leung, Karen Lynn, et al.
Publicado: (2020)

Lack of cyclical fluctuations of endometrial GLUT4 expression in women with polycystic ovary syndrome: Evidence for direct regulation of GLUT4 by steroid hormones
por: Cui, Peng, et al.
Publicado: (2015)

First Evidence of Genetic Association Between AKT2 and Polycystic Ovary Syndrome
por: Goodarzi, Mark O., et al.
Publicado: (2008)

MRNA Expression of Adipocytokines and Glucose Transporter Type 4 (GLUT4) in Adipose Tissue in Women With and Without Polycystic Ovary Syndrome
por: Ozga, Katarzyna Maria, et al.
Publicado: (2021)

SUN-008 Loss of Antimullerian Hormone Immunoreactivity Due to a Homozygous AMH Gene Mutation Rs10417628 in a Woman with Classical Polycystic Ovary Syndrome
por: Hoyos, Luis R, et al.
Publicado: (2020)

OR35-05 Interaction of Cortisol with Testosterone Predicts Abdominal Fat Mass in Normal-weight Polycystic Ovary Syndrome Women with Normal Serum 11-Oxygenated Androgens
por: Anthony Dumesic, Daniel, et al.
Publicado: (2023)

SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023)

Role of metformin in functional endometrial hyperplasia and polycystic ovary syndrome involves the regulation of MEG3/miR-223/GLUT4 and SNHG20/miR-4486/GLUT4 signaling
por: Liu, Jie, et al.
Publicado: (2022)

Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome
por: Wang, Yunhui, et al.
Publicado: (2013)

Harnessing Expression Data to Identify Novel Candidate Genes in Polycystic Ovary Syndrome
por: Jones, Michelle R., et al.
Publicado: (2011)

Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome
por: Xu, Ning, et al.
Publicado: (2015)

Therapeutic potential of exosomes/miRNAs in polycystic ovary syndrome induced by the alteration of circadian rhythms
por: Chen, Wei-hong, et al.
Publicado: (2022)

SUN-107 Abdominal Adipose Stem Cell Dysfunction In Vitro May Reflect Adipose Insulin Resistance In Vivo in Normal Weight Polycystic Ovarian Syndrome Women
por: Leung, Karen, et al.
Publicado: (2019)

Circulating and Adipose Tissue miRNAs in Women With Polycystic Ovary Syndrome and Responses to High-Intensity Interval Training
por: Lionett, Sofie, et al.
Publicado: (2020)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

Circulating miRNAs in Women with Polycystic Ovary Syndrome: A Longitudinal Cohort Study
por: Udesen, Pernille B., et al.
Publicado: (2023)

Differential expression of plasma‑derived exosomal miRNAs in polycystic ovary syndrome as a circulating biomarker
por: Liu, Yanfei, et al.
Publicado: (2023)

Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome
por: Baracat, Maria Candida P., et al.
Publicado: (2023)

SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023)

PMON244 Alterations in Nonesterified Free Fatty Acids (NEFA) Trafficking Rather Than Hyperandrogenism Contribute to Variations in Insulin Sensitivity Among Obese Women with Polycystic Ovary Syndrome
por: Azziz, Ricardo, et al.
Publicado: (2022)

MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
por: Cirillo, Francesca, et al.
Publicado: (2019)

Components of the Complement Cascade Differ in Polycystic Ovary Syndrome
por: Butler, Alexandra E., et al.
Publicado: (2022)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

Identification of key genes and miRNAs related to polycystic ovary syndrome by comprehensive analysis of microarray
por: Sun, Ziqian, et al.
Publicado: (2022)

Classical and alternate complement factor overexpression in non-obese weight matched women with polycystic ovary syndrome does not correlate with vitamin D
por: Moin, Abu Saleh Md, et al.
Publicado: (2022)

Improved Insulin Sensitivity by GLUT12 Overexpression in Mice
por: Purcell, Scott H., et al.
Publicado: (2011)

Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
por: Naji, Mohammad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j0liubgtu6nd65v2mf3ptnuj2f